IL139705A0 - Novel method for gene cloning - Google Patents

Novel method for gene cloning

Info

Publication number
IL139705A0
IL139705A0 IL13970599A IL13970599A IL139705A0 IL 139705 A0 IL139705 A0 IL 139705A0 IL 13970599 A IL13970599 A IL 13970599A IL 13970599 A IL13970599 A IL 13970599A IL 139705 A0 IL139705 A0 IL 139705A0
Authority
IL
Israel
Prior art keywords
protein
novel method
gene cloning
membrane
gene encoding
Prior art date
Application number
IL13970599A
Other languages
English (en)
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of IL139705A0 publication Critical patent/IL139705A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL13970599A 1998-05-20 1999-04-30 Novel method for gene cloning IL139705A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13865298 1998-05-20
JP27987698 1998-10-01
PCT/JP1999/002341 WO1999060113A1 (en) 1998-05-20 1999-04-30 Novel method for isolating gene

Publications (1)

Publication Number Publication Date
IL139705A0 true IL139705A0 (en) 2002-02-10

Family

ID=26471649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13970599A IL139705A0 (en) 1998-05-20 1999-04-30 Novel method for gene cloning

Country Status (13)

Country Link
US (3) US6610485B1 (de)
EP (1) EP1081224B1 (de)
JP (1) JP3471006B2 (de)
KR (1) KR100518958B1 (de)
CN (1) CN1310758A (de)
AT (1) ATE329020T1 (de)
AU (1) AU753310B2 (de)
CA (1) CA2331917A1 (de)
DE (1) DE69931776T2 (de)
IL (1) IL139705A0 (de)
NO (1) NO20005810L (de)
TW (1) TW593679B (de)
WO (1) WO1999060113A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060113A1 (en) * 1998-05-20 1999-11-25 Chugai Seiyaku Kabushiki Kaisha Novel method for isolating gene
JP5021143B2 (ja) 2000-09-14 2012-09-05 株式会社リバース・プロテオミクス研究所 医療および他の用途に用いる化合物の発見および創製のための方法
US20090137416A1 (en) 2001-01-16 2009-05-28 Regeneron Pharmaceuticals, Inc. Isolating Cells Expressing Secreted Proteins
KR20100039911A (ko) * 2001-10-13 2010-04-16 아스테리온 리미티드 폴리펩타이드들을 포함하는 글리코실포스파티딜이노시톨
US20080020376A1 (en) * 2004-03-10 2008-01-24 Akopian Armen N Enriched Cdna Expression Libraries and Methods of Making and Using Same
ES2645431T3 (es) * 2012-07-06 2017-12-05 Innovative Technologies In Biological Systems S.L. Polipéptido de fusión fluorescente, biosensor que comprende dicho polipéptido y usos de los mismos
TW202423993A (zh) 2012-11-14 2024-06-16 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
WO2025252840A1 (en) * 2024-06-04 2025-12-11 Technische Universitaet Muenchen, In Vertretung Des Freistaates Bayern Half-life modulation by a tag comprising at least one constant domain of an immunoglobulin light chain

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474899A (en) * 1987-05-13 1995-12-12 Cistron Biotechnology, Inc. Selective immunoassay for IL-1 β
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
CA2097617A1 (en) * 1990-11-23 1992-05-23 Brian Seed Inhibition of cell adhesion protein-carbohydrate interactions
US6099842A (en) 1990-12-03 2000-08-08 The United States Of America As Represented By The Department Of Health And Human Services Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
US5571894A (en) * 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1993007286A1 (en) 1991-09-30 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Recombinant immunotoxins
JP2879303B2 (ja) 1993-01-14 1999-04-05 佑 本庶 ｃＤＮＡライブラリーの作製方法、および新規なポリペプチドとそれをコードするＤＮＡ
US5817308A (en) * 1994-02-14 1998-10-06 University Of Rochester Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof
EP0832209A1 (de) 1995-06-07 1998-04-01 ZymoGenetics, Inc. Methode zum einfangen und klonieren der zur förderung der sekretion notwendigen leitsequenzen
WO1997040146A1 (en) 1996-04-24 1997-10-30 Genetics Institute, Inc. Yeast invertase gene as reporter system for isolating cytokines
JP2002238557A (ja) 1996-07-23 2002-08-27 Fujisawa Pharmaceut Co Ltd トランスメンブレントラップ法
JPH1132779A (ja) * 1997-07-24 1999-02-09 Fujita Gakuen 蛋白質の遺伝子クローニング法
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells
EP1073771B1 (de) 1998-04-30 2004-12-01 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Neue methode zur selektion von klonen einer expressionsbibliothek mittels "rearraying"
WO1999060113A1 (en) * 1998-05-20 1999-11-25 Chugai Seiyaku Kabushiki Kaisha Novel method for isolating gene

Also Published As

Publication number Publication date
KR100518958B1 (ko) 2005-10-06
EP1081224B1 (de) 2006-06-07
US6610485B1 (en) 2003-08-26
EP1081224A4 (de) 2003-07-02
NO20005810L (no) 2001-01-22
CN1310758A (zh) 2001-08-29
WO1999060113A1 (en) 1999-11-25
US20030175794A1 (en) 2003-09-18
NO20005810D0 (no) 2000-11-17
AU3628399A (en) 1999-12-06
AU753310B2 (en) 2002-10-17
US20050019780A1 (en) 2005-01-27
DE69931776T2 (de) 2007-05-16
ATE329020T1 (de) 2006-06-15
JP3471006B2 (ja) 2003-11-25
US7338797B2 (en) 2008-03-04
EP1081224A1 (de) 2001-03-07
TW593679B (en) 2004-06-21
CA2331917A1 (en) 1999-11-25
DE69931776D1 (de) 2006-07-20
KR20010043688A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
WO1999063088A8 (en) Membrane-bound proteins and nucleic acids encoding the same
AU8817391A (en) Method for the production of antibodies
SI2374872T1 (sl) Metoda za izražanje aktivnih fuzijskih beljakovin Ig pripadnikov družine receptorjev za TNF na visoki ravni in njihovo čiščenje
IL132249A0 (en) Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
WO2000032776A3 (en) Secreted amd transmembrane polypeptides and nucleic acids encoding the same
AU3188999A (en) Development of human monoclonal antibodies and uses thereof
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
EP2248899B8 (de) NOGO Rezeptor bindendes Protein
IL139705A0 (en) Novel method for gene cloning
WO1998022510A3 (en) Methods for the production of chicken monoclonal antibodies
KR100468977B1 (ko) 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
AR020701A1 (es) Acidos nucleicos y polipeptidos homologos il-17, vectores, celulas huesped, metodos y usos de los mismos.
DK1609863T3 (da) Udskilte polypeptider og transmembranpolypeptider samt nucleinsyrer kodende for disse
WO2001051635A3 (en) Novel stra6 polypeptides
WO2004043403A3 (en) Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
SI1181366T1 (sl) Sesalski receptorski proteini; sorodni reagenti in postopki
AU2003283240A1 (en) Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
EP1304574A3 (de) Elisa Bestätigungstest für frühe Primarinfektion durch Zytomegaloviren
WO2002074904A3 (en) Rearranged squamous cell carcinoma antigen genes ii
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
WO2003087128A3 (en) Secretory signal sequences and uses thereof
WO1999063093A3 (en) Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO1998057986A3 (en) Human preprotachykinin b
KR100515858B1 (en) PRO617 Polypeptides